EPIMMUNE INC
10-Q, EX-27.1, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: EPIMMUNE INC, 10-Q, EX-10.76, 2000-08-14
Next: CERRITOS VALLEY BANCORP, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM SEC FORM
10-Q FOR THE SIX MONTHS ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           1,590
<SECURITIES>                                     8,378
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                   652
<PP&E>                                           1,226
<DEPRECIATION>                                     322
<TOTAL-ASSETS>                                  14,839
<CURRENT-LIABILITIES>                            1,723
<BONDS>                                            416<F1>
                                0
                                         14
<COMMON>                                            73
<OTHER-SE>                                      12,564<F2>
<TOTAL-LIABILITY-AND-EQUITY>                    14,839
<SALES>                                              0
<TOTAL-REVENUES>                                 1,974
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 2,873<F3>
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  32
<INCOME-PRETAX>                                (2,168)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (2,168)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,168)
<EPS-BASIC>                                   (0.33)
<EPS-DILUTED>                                   (0.33)
<FN>
<F1>Includes bonds, mortgages and other long-term debt, including capitalized
leases.
<F2>Includes additional paid in capital, other additional capital and retained
earnings, appropriated and unappropriated (excludes unrealized loss on
securities)
<F3>Per Chief Accountant at SEC, this amount excludes sales and G&A expenses,
includes costs and expenses applicable to sales and revenues, and tangible
costs of goods sold.
</FN>


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission